バルスポダール

バルスポダール 価格

バルスポダール 化学特性,用途語,生産方法

• 効能

  抗悪性腫瘍薬, P-糖タンパク質阻害薬

• 説明

  PSC 833 is a non-immunosuppressant derivative of cyclosporine and potent multidrug-resistance (MDR) modulator. It restores sensitivity of MDR-P388 murine leukemia cells to cytostatic agents when used at concentrations of 70, 33, 45, 34, and 26 nM in combination with colchicine, vincristine , daunorubicin , doxorubicin , and etoposide , respectively. PSC 833 inhibits basal-to-apical transport and increases apical-to-basal transport of [¹⁴C]docetaxel in LLC-GA5-COLO150 cells that overexpress human P-glycoprotein (P-gp). In vivo, PSC 833 increases survival time in MDR-P388 tumor-bearing mice and in an MDR-L1210 leukemia mouse xenograft model when administered in combination with doxorubicin. PSC 833 also prolongs the anti-hyperalgesic effects of intraperitoneally administered pregabalin in a mouse model of cold stress-induced central pain.

• 化学的特性

  White Solid

• 使用

  Valspodar/ PSC-833 has been used as a ABCB1 (P-glycoprotein) inhibitor.

• 細胞毒性(Cytotoxicity)

  Cells treated with increasing concentrations of valspodar over a 9-day period show minimal cytotoxicity. It appears to be neither immunosuppressive nor nephrotoxic with the ability to achieve levels in the blood (1 μm) capable of reversing drug resistance without excessive toxicity[1].

バルスポダール 生産企業

Global(125)Suppliers

バルスポダール スペクトルデータ(MS)

121584-18-7, バルスポダール キーワード